Lincoln National Corp Astrazeneca PLC Transaction History

Lincoln National Corp

$3.11 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$61.03 - $69.57 $260,781 - $297,272	4,273 Added 13.06%	36,999 $2.51 Million
Q4 2023 Feb 06, 2024	BUY	$61.89 - $69.28 $55,639 - $62,282	899 Added 2.82%	32,726 $2.2 Million
Q3 2023 Nov 03, 2023	BUY	$64.85 - $71.7 $61,866 - $68,401	954 Added 3.09%	31,827 $2.16 Million
Q2 2023 Aug 04, 2023	BUY	$69.91 - $75.81 $85,150 - $92,336	1,218 Added 4.11%	30,873 $2.21 Million
Q1 2023 May 01, 2023	BUY	$63.15 - $71.6 $179,661 - $203,701	2,845 Added 10.61%	29,655 $2.06 Million
Q4 2022 Feb 07, 2023	SELL	$54.21 - $70.44 $228,278 - $296,622	-4,211 Reduced 13.57%	26,810 $1.82 Million
Q3 2022 Nov 03, 2022	BUY	$53.02 - $135.75 $31,865 - $81,585	601 Added 1.98%	31,021 $1.7 Million
Q2 2022 Aug 02, 2022	SELL	$59.26 - $71.14 $32,889 - $39,482	-555 Reduced 1.79%	30,420 $2.01 Million
Q1 2022 May 09, 2022	BUY	$55.72 - $67.12 $47,529 - $57,253	853 Added 2.83%	30,975 $2.06 Million
Q4 2021 Jan 26, 2022	SELL	$54.02 - $63.83 $26,091 - $30,829	-483 Reduced 1.58%	30,122 $1.76 Million
Q3 2021 Nov 05, 2021	BUY	$55.56 - $60.79 $940,075 - $1.03 Million	16,920 Added 123.64%	30,605 $1.84 Million
Q2 2021 Aug 13, 2021	BUY	$48.42 - $60.18 $100,665 - $125,114	2,079 Added 17.91%	13,685 $819,000
Q1 2021 May 10, 2021	BUY	$47.16 - $54.44 $11,742 - $13,555	249 Added 2.19%	11,606 $577,000
Q4 2020 Feb 05, 2021	BUY	$48.52 - $58.02 $30,761 - $36,784	634 Added 5.91%	11,357 $568,000
Q3 2020 Nov 09, 2020	BUY	$53.07 - $61.1 $49,248 - $56,700	928 Added 9.47%	10,723 $588,000
Q2 2020 Jul 31, 2020	BUY	$43.1 - $55.31 $100,336 - $128,761	2,328 Added 31.18%	9,795 $518,000
Q1 2020 Apr 24, 2020	BUY	$37.79 - $51.33 $103,695 - $140,849	2,744 Added 58.1%	7,467 $333,000
Q4 2019 Feb 07, 2020	BUY	$42.46 - $50.46 $200,538 - $238,322	4,723 New	4,723 $235,000
Q3 2019 Nov 06, 2019	SELL	$40.12 - $45.47 $236,587 - $268,136	-5,897 Closed	0 $0
Q2 2019 Aug 06, 2019	BUY	$37.28 - $41.68 $219,840 - $245,786	5,897 New	5,897 $243,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.05 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.71 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.4 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.37 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.1M
Shares

$1.23 Billion
0.45% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lincoln National Corp with notifications on news.

Account